Prospera Financial Services Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Prospera Financial Services Inc

  • $3.5 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
SELL
$83.14 - $145.99 $112,155 - $196,940
-1,349 Closed
0 $0
Q1 2022

May 04, 2022
BUY
$110.08 - $142.92 $148,497 - $192,799
1,349 New
1,349 $160,000
Q4 2020

Feb 12, 2021
SELL
$65.07 - $98.24 $126,431 - $190,880
-1,943 Closed
0 $0
Q3 2020

Nov 04, 2020
BUY
$59.04 - $77.95 $114,714 - $151,456
1,943 New
1,943 $126,000

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
785K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.65B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email